FDA Clears ReWalk Technology as First Personal Exoskeleton to Allow Use on Stairs and Curbs

Time Stamp: March 7, 2023 8:57 AM
Source Node: 1997836

The medical world is abuzz with the news that the U.S. Food and Drug Administration (FDA) has cleared ReWalk Technology as the first personal exoskeleton to allow use on stairs and curbs. This is a major breakthrough for those with lower limb disabilities, as it provides them with a new level of mobility and independence.

ReWalk Technology is a robotic exoskeleton designed to enable individuals with lower limb disabilities to stand and walk. The device is powered by a rechargeable battery and controlled by a wireless remote or an app on the user’s smartphone. It is designed to enable users to walk up and down stairs, as well as navigate curbs and other uneven surfaces.

The FDA clearance of ReWalk Technology marks a major milestone in the development of assistive technology for those with lower limb disabilities. This technology has the potential to improve the quality of life for many individuals, as it provides them with increased mobility and independence. It also has the potential to reduce the need for wheelchairs, which can be difficult to maneuver in certain environments.

The FDA clearance of ReWalk Technology is also a significant step forward in the development of assistive technology for those with lower limb disabilities. This technology has the potential to revolutionize the way individuals with lower limb disabilities interact with their environment, providing them with increased freedom and independence.

The FDA clearance of ReWalk Technology is an exciting development for those with lower limb disabilities, as it provides them with a new level of mobility and independence. This technology has the potential to revolutionize the way individuals with lower limb disabilities interact with their environment, providing them with increased freedom and independence.

Time Stamp:

More from Crowdfunding / Web3